These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6889150)

  • 21. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombin-antithrombin complex in healthy subjects and patients with various diseases].
    Deguchi K; Iwasaki E; Noguchi M; Ohkubo I; Deguchi A; Mori Y; Tsukada T; Tuda M; Wada H; Murashima S
    Rinsho Ketsueki; 1988 Nov; 29(11):2048-53. PubMed ID: 3070074
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative management of a congenital antithrombin deficient patient on chronic hemodialysis.
    Hara T; Jojima K; Takeuchi K; Takai K; Naito K
    Thromb Haemost; 2004 Jul; 92(1):208-10. PubMed ID: 15213863
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin-III and platelets in haemodialysis patients.
    Brandt P; Jespersen J; Sørensen LH
    Nephron; 1981; 28(1):1-3. PubMed ID: 7266723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemostatic changes during hemodialysis of patients with chronic kidney insufficiency].
    Randelović S; Krstić C; Susa S; Dumović B; Malesević M; Pantović R; Butorajac J; Durutović R; Lazić D; Ninković D
    Vojnosanit Pregl; 1982; 39(5):344-8. PubMed ID: 7164346
    [No Abstract]   [Full Text] [Related]  

  • 27. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sequential ultrafiltration with hemodialysis in treating chronic kidney failure].
    Kulakov GP; Konovalov GA; Melikian AM; Makarova KM
    Urol Nefrol (Mosk); 1983; (1):34-9. PubMed ID: 6829090
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of hemodialysis on serum levels of glycocholic acid in patients with chronic renal failure].
    Kowalski D; Starzyk J; Kowalska K
    Wiad Lek; 1987 Dec; 40(23):1585-7. PubMed ID: 3451586
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activity of plasma renin in patients with terminal renal insufficiency kept on chronic hemodialysis].
    Lifshits NL; Ermolenko VM; Sumarokov AV; Tatsievskiĭ VA; Kondakhchan MA
    Ter Arkh; 1975; 47(4):81-8. PubMed ID: 1145487
    [No Abstract]   [Full Text] [Related]  

  • 31. [Utilization of sodium acetate by patients with chronic renal failure on chronic hemodialysis].
    Oulès R; Branger B; Chevallet M; Polito C; Desch G; Descomps B; Mion C
    J Urol Nephrol (Paris); 1978; 84(4-5):340-4. PubMed ID: 682237
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyperglucagonemia in patients with chronic renal failure treated by repeated hemodialysis].
    Czekalski S; Słuczanowski W; Gryczyńska M; Toczkowski M; Gołebiowska I; Nowotko U
    Pol Arch Med Wewn; 1980 Aug; 64(2):117-23. PubMed ID: 7433151
    [No Abstract]   [Full Text] [Related]  

  • 33. [Total serum lipids in chronic renal failure treated by repeated hemodialysis and kidney transplantation].
    Juskowa J; Barańska E
    Pol Arch Med Wewn; 1981 Jul; 66(1):33-41. PubMed ID: 7027199
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease.
    Kaneva K; Bansal V; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2013; 19(4):449-52. PubMed ID: 23463188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasma insulin and growth hormone levels during hemodialysis in patients with chronic renal failure].
    Czekalski S; Czarnecki R; Kosowicz J
    Pol Arch Med Wewn; 1972; 48(6):569-76. PubMed ID: 5043937
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gentamicin pharmacokinetics during hemodialysis].
    Takasugi M; Hasegawa O; Soejima M; Yu K; Muta T; Matsuura K; Nakashima Y; Kuroiwa A; Kunifuji Y; Nakamura T
    Nihon Jinzo Gakkai Shi; 1984 Nov; 26(11):1509-19. PubMed ID: 6533375
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W; Glöckner WM; Müller N
    Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood serum ferritin level in patients with chronic renal failure treated by repeated hemodialysis].
    Kowalski D; Starzyk J
    Wiad Lek; 1988 Oct; 41(19):1274-8. PubMed ID: 3247742
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of long-term hemodialysis on changes in the concentration of various trace elements in the blood of patients with chronic renal failure].
    Weyde W; Adamiec R
    Pol Tyg Lek; 1983 Jan; 38(2):45-9. PubMed ID: 6856497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.